Effects of adenosine A2Aand A2B receptor activation on signaling pathways and cytokine production in human uroepithelial cells

Pharmacology

Volumn 86, Issue 3, 2010, Pages 129-137

  Säve, Susanne ^a   Persson, Katarina ^a,b  

^a LINNAEUS UNIVERSITY   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adenosine receptors; Cyclic AMP; Interleukin 8; Urinary tract infection; Uropathogenic Escherichia coli

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOPROTEIN; STAT3 PROTEIN;

ARTICLE; CYTOKINE PRODUCTION; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; ESCHERICHIA COLI; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UROTHELIUM; WESTERN BLOTTING;

ADENOSINE; ADENOSINE A2 RECEPTOR AGONISTS; CELL LINE; CYCLIC AMP; CYTOKINES; GENE EXPRESSION; HUMANS; INTERLEUKIN-8; PHENETHYLAMINES; PHOSPHOPROTEINS; PHOSPHORYLATION; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A2A; RECEPTOR, ADENOSINE A2B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UROPATHOGENIC ESCHERICHIA COLI; UROTHELIUM;

EID: 77955110191     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000317068     Document Type: Article

References (29)

1. Hasko G, Cronstein BN: Adenosine: an endogenous regulator of innate immunity. Trends Immunol 2004; 25:33-39.
2. 2A receptors. Annu Rev Immunol 2004; 22: 657-682.
3. Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J: International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 2001; 53: 52 7-552.
4. Linden J: New insights into the regulation of inflammation by adenosine. J Clin Invest 2006; 116:1835-1837.
5. Svanborg C, Bergsten G, Fischer H, Godaly G, Gustafsson M, Karpman D, Lundstedt AC, Ragnarsdottir B, Svensson M, Wullt B: Uropathogenic Escherichia coli as a model of host-parasite interaction. Curr Opin Micro-biol 2006; 9: 33-39.
6. Save S, Mjosberg J, Poljakovic M, Mohlin C, Persson K: Adenosine receptor expression in Escherichia coli-infected and cytokine-stim-ulated human urinary tract epithelial cells. BJU Int 2009; 104:1758-1765.
7. Phelps PT, Anthes JC, Correll CC: Characterization of adenosine receptors in the human bladder carcinoma T24 cell line. Eur J Pharmacol 2006; 53 6: 28-37.
8. Ohta A, Sit kovsk y M: Role of G-protei n-cou-pled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 2001; 414: 916-9 2 0.
9. Zidek Z: Adenosine-cyclic AMP pathways and cytokine expression. Eur Cytokine Netw 1999; 10:319-32 8.
10. Bouma MG, Stad RK, van den Wildenberg FA, Buurman WA: Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J Immunol 1994; 153: 4159-4168.
11. 2A signaling. Prog Neurobiol 2007; 83: 263-276.
12. Fredholm BB, Arslan G, Halldner L, Kull B, Schulte G, Wasserman W: Structure and function of adenosine receptors and their genes. Naunyn Schmiedebergs Arch Pharmacol 2000; 362:364-374.
13. 2B receptors. Pharmacol Rev 1997; 49:381-402.
14. Schulte G, Fredholm BB: Signalling from adenosine receptors to mitogen-activated protein kinases. Cell Signal 2003; 15: 81 3-8 2 7.
15. Rossi MR, Masters JR, Park S, Todd JH, Gar-rett SH, Sens MA, Somji S, Nath J, Sens DA: The immortalized UROtsa cell line as a potential cell culture model of human urothe-lium. Environ Health Perspect 2001; 109: 801-808.
16. 2a-adenosine receptor-mediated cAMP response. J Biol Chem 1997; 272:4970-4977. (Pubitemid 27090048)
17. Song J, Bishop BL, Li G, Duncan MJ, Abraham SN: TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder. Cell Host Microbe 2007; 1:287-298.
18. Song J, Bishop BL, Li G, Grady R, Stapleton A, Abraham SN: TLR4-mediated expulsion of bacteria from infected bladder epithelial cells. Proc Natl Acad Sci USA 2009; 106: 1496 6-14971.
19. Hodge DR, Hurt EM, Farrar WL: The role of IL-6 and STAT3 in inflammation and cancer. Eur J Cancer 2005; 41:2502-2512.
20. 2A adenosine receptor in vivo. J Immunol 2004; 173:21-24.
21. Bshesh K, Zhao B, Spight D, Biaggioni I, Feokistov I, Denenberg A, Wong HR, Shan-ley TP: The A #INF#2#/INF#A receptor mediates an endogenous regulatory pathway of cytokine expression in THP-1 cells. J Leukoc Biol 2002; 72:1027-1036.
22. Tak PP, Firestein GS: NF-KB: a key role in inflammatory diseases. J Clin Invest 2001; 107:7-11.
23. 2B adenosine receptor protects against inflammation and excessive vascular adhesion. J Clin Invest 2006; 116: 1913-1923.
24. 2B adenosine receptor gene ablation on adenosine-dependent regulation of proinf lammatory cytokines. J Pharmacol Exp Ther 2008; 324:694-700.
25. Song J, Duncan MJ, Li G, Chan C, Grady R, Stapleton A, Abraham SN: A novel TLR4-mediated signaling pathway leading to IL-6 responses in human bladder epithelial cells. PLoS Pathog 2007; 3:e60.
26. Schilling JD, Martin SM, Hunstad DA, Patel KP, Mulvey MA, Justice SS, Lorenz RG, Hult-gren SJ: CD14-and Toll-like receptor-dependent activation of bladder epithelial cells by lipopolysaccharide and type 1 piliated Esch-erichia coli. Infect Immun 20 03; 71: 14 7 0-148 0.
27. Hedlund M, Svensson M, Nilsson A, Duan RD, Svanborg C: Role of the ceramide-sig-naling pathway in cytokine responses to P-fimbriated Escherichia coli. J Exp Med 1996; 18 3: 1037-10 4 4.
28. Tsai KW, Lai HT, Tsai TC, Wu YC, Yang YT, Chen KY, Chen CM, Li YS, Chen CN: Difference in the regulation of IL-8 expression induced by uropathogenic E. coli between two kinds of urinary tract epithelial cells. J Biomed Sci 2009; 16: 91.
29. 2A adenosine receptor on the profile of chemokines produced by neutrophils. FASEB J 2006; 20:187-189.